New Pharmacology for Weight Loss with Dr. Gurdeep Singh

Journal of Investigative Medicine Podcast

Indhold leveret af BMJ Group. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af BMJ Group eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

2+ y ago 25:43

MP3•Episode hjem

Arkiveret serie ("Inaktivt feed" status)

When? This feed was archived on October 16, 2023 12:08 (6M ago). Last successful fetch was on July 13, 2023 21:21 (9M ago)

Why? Inaktivt feed status. Vores servere kunne ikke hente et gyldigt podcast-feed i en længere periode.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum speaks with Dr. Gurdeep Singh, the first author of the review entitled “Wegovy(Semaglutide) a new weight loss drug for chronic weight management” which was Editor’s choice in the upcoming January issue of the Journal of Investigative Medicine.

Dr. Gurdeep Singh, MD, FACE a Clinical Endocrinologist from Lake Erie College of Osteopathic Medicine at Our Lady of Lourdes Memorial Hospital in Binghamton, New York.

34 episoder

#Science #BMJ Group #Jim Editor